On December 20, 2024 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") reported that its management will present and host 1×1 meetings at the 43rd Annual J.P. Morgan Healthcare Conference being held on January 13-16, 2025 in San Francisco, CA (Press release, Innate Pharma, DEC 20, 2024, View Source [SID1234649237]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jonathan Dickinson, Chief Executive Officer of Innate Pharma, will represent the Company in a session scheduled Tuesday, January 14, 2025 from 11:15 – 11:55 am PST.

Other Executive Board members participating in the event will be:
•Dr Sonia Quaratino, EVP, Chief Medical Officer
•Yannis Morel, EVP, Chief Operating Officer
•Arvind Sood, EVP, President of US Operations

A live video webcast of the presentation will be accessible under the "Events" tab on the Investors section of the Company’s website at www.innate-pharma.com and will be available for replay following the event.